Medelife geht ab

translate.googleusercontent.com/...FIRXV41_fUT7bGZKfno_zlPR2ug

translate.googleusercontent.com/..._N9ZflzOtDAsAQSYOKLsudMWX6w

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






 Item 3.02 Unregistered Shares of Equity Securities

On June 29, 2010, Medefile International, Inc. (the “Company”)   accepted subscriptions for an aggregate of 1,000,000,000 shares of the common stock for a per share purchase price of $0.001.  Lyle Hauser, the son of the Company’s Chief Executive Officer, as lead investor, invested $250,000 in the private placement. The Company received net proceeds from the private placement of $1,000,000.  The offering was made solely to “accredited investors,” as that term is defined in Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). The securities sold in the offering were not registered under the Securities Act, or the securities laws of any state, and were offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws, which exempt transactions by an issuer not involving any public offering.

In connection with the private placement, Lyle Hauser also agreed to return and forfeit warrants to purchase an aggregate of 90,000,000 shares of common stock that he had acquired in a May 2010 private placement (the “Warrant Cancellation”).  The Warrant Cancellation resulted in an effective reduction in the per share purchase price paid by Lyle Hauser in the May 2010 private placement from $0.002 per share to $0.001 per share.  In consideration for the Warrant Cancellation, Lyle Hauser received an additional 450,000,000 shares of common stock.


 Item 9.01 Financial Statements and Exhibits

(d)           Exhibits.

Exhibit No.
          §
Description
10.1
          §
Form of Subscription Agreement






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  MEDEFILE INTERNATIONAL, INC.
     
Date:  July 13, 2010
          §
By:
          §/s/  Milton Hauser
    Name:  Milton Hauser
    Title: Chief Executive Officer
     



EXHIBIT INDEX

Exhibit No.
          §
Description
10.1
          §
Form of Subscription Agreement

Mr. Mofshin brings his expertise in direct response marketing and his venture capital credentials to MedeFile with the intention of further developing and effectively executing MedeFile's long term marketing agenda.

"Identifying emerging fields in business of potentially massive growth is a big part of what I do, " said Mr. Mofshin, "and Personal Health Records is a field that is clearly exploding onto the healthcare scene. I look forward to bringing my experience in direct response marketing to bear on MedeFile's already impressive marketing strategy in order to help MedeFile reach as broad a spectrum of customers as possible."

Kevin Hauser, Director, Business Development of MedeFile, said, "Howard Mofshin is a peerless marketing innovator whose experience in the field of direct response is unparalleled. Howard is an expert in bringing great products and services to massive numbers of people." Mr. Hauser added that, "having Howard on our team can potentially result in a level of growth previously unforeseen within MedeFile."

About MedeFile International, Inc.

Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com

Safe Harbor Statement Under the Private Securities Litigation Act of 1995

With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

CONTACT:  

MedeFile

561-912-3393

investor@medefile.com

SOURCE MedeFile International, Inc.

auf gehts zum zweiten ANLAUF. Die Berichte wären alle gut, was fehlt ist interesse.....

Das ist meine pers. Meinung und keine Kaufanregung!!!

translate.googleusercontent.com/...C07d5WfvvmW-rAXBnQ-33C1Ppgg

www.ddmachine.com/default.asp

biz.yahoo.com/pz/100728/197699.html?.v=1

--------------------------------------------------

Sneaky, sneaky Patriot National Bancorp (NASDAQ:PNBK). This small cap stock - whoops, another micro cap - has been making very little noise of late, but has actually been making huge progress. I opted to use a weekly chart rather than a daily chart to show you want I mean.

In simplest terms, PNBK has moved from under all of its key moving averages to above them all. More importantly, it's done the deed in a controlled, methodical manner. Translation? I think this rally effort has some healthy longevity; it's got some volume behind it too.

To be fair, I do think Patriot National Bancorp is a little overbought at the current price of $2.42. We saw a similar jump in April, only to watch all of that gain given back by June. This one's far healthier than that one, but I'd still advocate waiting for a pullback and regrouping. The gas is in the tank though.

% Owned by Institutions
          §0.00 %
Market Cap.
          §
$ 8,778,129
Trading Volume - Today
          §3,210,100
Trading Volume - Average
          §3,008,700
Trading Volume - Today vs. Average
          §0.81 %
Earnings Per Share
          §
PE Ratio
          §
Record Date
          §2010-AugA
Sector
          §Technology
Industry
          §Healthcare Information Services
Exchange
          §BB
Data Provided Without Warranty

stockcharts.com/h-sc/ui
mdfi einfügen

de.advfn.com/...art&s=NB%5EMDFI&p=0&t=39&vol=1

EMRs provide the foundation for analytics that can improve patient outcomes and vastly drive down health care costs. A holistic view of patients’ full medical history could make the whole concept of preventative medicine a reality. Businesses across various industries are already using data analytics to better understand and serve their clients’ needs. This concept can be extended to the health care space—providing a sophisticated way to analyze patient records to understand individual risk factors and encourage patient to get regular check-ups. Through preventative medicine, health problems are discovered and treated earlier, improving patient care while saving money.

Transitioning from the “sick-care” model to preventative care requires an integrated data set. Instead of approaching document capture at the individual department or provider level, providers need to take a broader approach to information storage and sharing. This will result in significant improvements in the delivery of care.

Patient Benefits
Swift access to the right medical data saves lives. Knowledge about diabetic or epileptic patients, for example, is tremendously helpful in first-responder situations.

No matter when and where a patient is being treated, full, accurate medical information is necessary for improving care. Diagnosing patients accurately is predicated on the amount of knowledge the doctor has about the patient. Imagine, for example, if health care providers had access to our entire medical history to make differential diagnoses right on the spot.

In addition, EMRs will enable a more holistic approach to caring for patients. Traditionally, there have been significant—and dangerous—gaps in critical health care information. Patients might visit five different care givers yet their data doesn’t always follow them, leading to misdiagnoses, inaccurate medication dosing, and other frightening errors. Ensuring highly portable health care information can save lives and improve the quality of care.

What the industry needs is a straightforward way to transmit data electronically from provider to vendor to patient.

EMR Hurdles
Not surprisingly, the transition to EMRs is cause for confusion and consternation. Organizations need to address issues such as data synchronization and access control. And they must contend with the serious worry of identity theft. Having one’s entire medical history and digital footprint in one place is a wonderful way to improve medical care but necessitates resolution of user authentication questions.

These IT challenges are not insurmountable. Various streaming and authentication technologies are maturing enough to enable organizations to capture data in a distributed format. For example, creating a smart card-like system requiring fingerprint authentication could be the right solution for delivering data portability and security.

The isolated nature of data models is the greatest challenge in today’s IT environments. While there are standards being developed for data portability, they are not being adopted across the board, and many of the propose standards don’t follow existing international standards.

We need to define a standard interface akin to the international standard for transfer of funds in the banking industry. Banks adopted a single standard that controls financial transactions, regardless of the institution involved. They have a vested interest in this common goal. Similarly, health care providers would benefit greatly from having a more streamlined information flow, dictated by a common set of standards.

Health care providers can no longer rely on labor-intensive, error-prone manual data sharing. EMRs add tremendous value across the health care supply chain. The move to digital, portable records is about much more than regulatory compliance. It’s about saving lives. But to achieve this lofty goal, the health care industry must open up its processes, accommodating ubiquitous sharing of medical records. The resulting benefits are impressive: a foundation to actually improve patient outcomes and make the most of every health care dollar.



--------------------------------------------------
Roy Devine is associate vice president for Patni Life Sciences, a unit of IT consulting firm Patni Computer Systems.
Click here to login and leave a comment.

0 Comments
Add Comment

Text Only 2000 character limit

Show all filings for MEDEFILE INTERNATIONAL, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MEDEFILE INTERNATIONAL, INC.

13-Aug-2010

Changes in Registrant's Certifying Accountant


Item 4.01 Changes in Registrant's Certifying Accountant

On August 10, 2010, the board of directors of Medefile International, Inc. (the "Company") dismissed Mallah Furman & Company PA ("Mallah Furman") as the Company's independent registered public accounting firm.

Mallah Furman has not issued a report on the Company's financial statements for years ended December 31, 2009 or December 31, 2008. During the fiscal year ended December 31, 2009, and any subsequent period through August 13, 2010, there were no reportable events as the term described in Item 304(a)(1)(iv) of Regulation S-K.

On August 13, 2010, the Company provided Mallah Furman with a copy of the disclosures it is making in response to Item 4.01 on this Form 8-K, and has requested that Mallah Furman furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statements. A copy of the letter, dated August 13, 2010 is filed as Exhibit
16.1 (which is incorporated by reference herein) to this Current Report on Form 8-K.

On August 10, 2010, the Company re-engaged L.L. Bradford & Company, LLC ("L.L. Bradford") as its independent registered public accounting firm for the Company's fiscal year ended December 31, 2010. LL Bradford had previously served as the Company's independent registered public accounting firm from November 4, 2008 through August 2, 2010. The change in the Company's independent registered public accounting firm was approved by the Company's Board of Directors on August 13, 2010.

From August 2, 2010 through August 10, 2010, the Company did not consult with L.L. Bradford regarding either (i) the application of accounting principles to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered on the Company's financial statements or (ii) any matter that was either the subject of a disagreement or event identified in response to
(a)(1)(iv) of Item 304 of Regulation S-K.

Item 9.01     Financial Statements and Exhibits

(d)
Exhibit No.   Description
16.1          Letter from Mallah Furman & Company PA dated August 13, 2010

ih.advfn.com/...mona&article=44028147&symbol=NB%5EMDFI

Revenues for the quarter ended June 30, 2010 totaled $4,242 compared to revenues of $2,716 during the quarter ended June 30, 2009. The increase in revenue is primarily related to an increase in the amount of members and medical record reimbursement revenue received from members. Medical record reimbursement revenue is a dollar for dollar reimbursement for charges from member’s doctors for sending updated medical records to Medefile. The off-setting expense is charged to selling general and administrative expense. The company has increased it marketing and advertising efforts, as a result there has been a substantial increase in memberships over the previous period. Revenues received from memberships are expenses through the period of the membership and therefore revenue recognized represents a fraction of the membership in the quarter being reported.

Kevin Hauser also stated, "MedeFile has become a powerful brand due to its state-of-the-art technology, relevance and necessity to our lives, and dedicated employees. I believe there is now an extraordinary opportunity to create value for our shareholders and new possibilities for our subscribers, partners and employees. I will do everything possible to make MedeFile the success it was created to be."

About MedeFile International, Inc.

Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com/

Safe Harbor Statement Under the Private Securities Litigation Act of 1995

With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

Contact: Investors, 1-888-241-0800, investor@medefile.com

MedeFile International, Inc.

CONTACT: Investors, +1-888-241-0800, investor@medefile.com

Web Site: www.medefile.com/


© 2010 PR Newswire

ihre Einschätzung! Mich nervt es schön langsam!

 

mich auch,wir müssen das hier längere zeit aushalten ich gebe kein stück her
die sollten mal melden wie viele kunden sie neu dazu gewonnen haben vorher brauchen wir gar nicht diskutieren
für mich persönlich bleibt es eine super spannende aktie mit der man sehr sehr viel geld verdienen kann nur die zeit wird es zeigen
alles nur meine meinung und long denken hoffe ich

finance.yahoo.com/q/is?s=mdfi.ob

das ist die aktie schlechthin. hat mir schon fast 1000% beschert und wird es auch weiterhin tun, nut grduld sollte man mitbringen...................

Always on the lookout for avenues to new, mass market opportunities (as well as some smaller, strategic ones) we have recently signed several pivotal distribution agreements that will provide immediate growth as well as ongoing opportunities to enhance our reach. Â Some of these agreements include National Safe Drivers (NSD), one of the country's largest suppliers of auto-related supplemental products, giving us direct access to their massive pool of auto-related customers (5 million+ individuals) and our joint venture agreement with The More Network (TMN), a premier provider of business-to-business solutions, products and services to the robust transportation industry.
* We are vertically marketing through private physician practices and have created our first-ever direct-to-consumer marketing campaign that has just recently launched.
We recently rolled out a revolutionary program targeted to physicians, which enables practices to seamlessly incorporate MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) 's PHR technology into their existing workflow. Â This program also allows electronic interfacing with EMR technology as well as paper based offices to market the MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) system as well. Â We expect this marketing campaign to result in a substantial flow of new MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) memberships from within each participating practice's patient base. We will continue to pursue vertical marketing through private physicians' offices, thus increasing our local and national footprint and improving consumer affinity for our brand through the explicit endorsement and direct recommendation of trusted health care providers.
* We continue to strengthen our cumulative experience, knowledge and influence with strategic, high-profile additions to our Board of Advisors.
We have recently welcomed Howard Mofshin to our Board of Advisors. Â He is the ground-breaking direct response marketing expert and successful venture capitalist who co-founded "Cash4Gold," one of the fastest growing companies in America. Â Mr. Mofshin, who ideated and instituted perhaps the most successful direct response commercial in television advertising history, brings his substantial experience and expertise in direct response marketing to MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) , with the goal of further developing and effectively executing our long-term marketing agenda.
* We have evolved the MedeFile brand and upgraded our website to reflect the corresponding growth in the company and new developments in technology, healthcare and in the field of PHR Technology.
The redesigned MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) website - clearer, more sophisticated, and more informative than ever - was recently launched to an overwhelmingly positive response. Â In concert with the redesign of our online presence, we've fine-tuned our Mission Statement: Â
To provide our members and the healthcare community with 21st Century solutions for navigating the increasingly complex and ever-changing healthcare and medical environment.
* Direct marketing is a key pillar of our overall growth strategy. After a comprehensive process of research and refinement, we are deploying an ambitious direct-to-consumer marketing campaign. This new campaign will enable even more reach and specificity in terms of the demographics we target. Â We anticipate this will result in more customers and increased growth of our subscriber base. Â MedeFile is now geared up to market to consumers directly through intensive direct response marketing and through various media such as TV, web video, social networks, and telemarketing. Â Early returns from these various campaigns are extremely promising.
In addition to all these efforts, we recently made huge strides in the expansion of our resources through significant new capital investment as well as via the recent strengthening of our balance sheet to make MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) totally free of debt, providing the company with substantial working capital for aggressive marketing campaigns. Â We are pleased to report that the new capital we have attracted was injected by long-term investors who share the vision of our management team. Â Additionally, our single largest shareholder has increased his equity position in MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) . Â Other shareholders should be comforted to know that our single largest shareholder is committed to the long term goals and success of MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) . Â This additional capital will support the anticipated growth in sales and marketing, scanning operations, fulfillment operations and call center operations that are mission critical for our overall expansion.
All of this capital - financial and otherwise - allows us to continue to develop newer and better solutions and to exploit growth opportunities, wherever and whenever they arise.
The ongoing efforts and developments described above have landed MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) at the center of the medical information technology revolution. This successful positioning has been made possible by the progressive and entrepreneurial vision of our management, the diligent and comprehensive work of our employees, and our strategic positioning and efficient use of capital.
On behalf of the entire MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) team, I hope that this update provides a clear picture of our many recent activities and developments, as well as an appreciation for the many successful outcomes we have achieved and expect to achieve on behalf of our shareholders.
Before I conclude, I want to add that I was honored this month to assume the position of Chief Executive Officer of MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) . Â As I take the helm from my capable predecessor (my father, Milton Hauser), I am proud to be leading this wonderful company during what I expect to be the most exciting time in its history. Â
I am strongly committed to increasing shareholder value and will do everything in my power serve your interests as a shareholder in MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) , and to communicate clearly with you as we continue to execute on our business plan. Â Thank you for the opportunity to provide this update on your investment in the future of healthcare information technology. Â
Sincerely yours,
Kevin Hauser
Chief Executive Officer, MedeFile (MDFI:$0.0055,$-0.0004,-6.78%)
About MedeFile International, Inc. (MDFI:$0.0055,$-0.0004,-6.78%)
Headquartered in South Florida, MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) 's primary product is the MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) system, a highly secure system for gathering and maintaining medical records. The MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) and its annual subscription-based programs, please visit www.medefile.com
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile (MDFI:$0.0055,$-0.0004,-6.78%) could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
Contact: Â Investors, MedeFile International, Inc. (MDFI:$0.0055,$-0.0004,-6.78%) , 1-888-241-0800, Â investor@medefile.com
SOURCE MedeFile International, Inc. (MDFI:$0.0055,$-0.0004,-6.78%)


Get more news on:SYMBOLS: MDFINEWS TYPE: SECTORS: Health Care Providers and Services, Health Care, Communications Equipment, Computers and Peripherals, Internet Software and Services, IT Services, Software, Information Technology, Electrical Equipment, Industrials

wenn das so weiter geht, säuft das Ding bis $ 0,002 ab und dann?

Ab besten man nimmt eine paar Schlaftabletten und schläft mal 3 Monate, vielleicht ist es bis dahin dann besser.

Reine Nervensache die Aktie!!!!!!!!!!!!!!!!!!!!!!!

Nur meine persönliche Meinung.

 

 

mit monaten ist das hier nicht getan, jahre wären nicht schlecht.......................aber wenns scheeeen reich macht:-)

% Owned by Institutions
          §
Market Cap.
          §
$ 5,852,086
Trading Volume - Today
          §3,210,100
Trading Volume - Average
          §4,588,800
Trading Volume - Today vs. Average
          §0.81 %
Earnings Per Share
          §
PE Ratio
          §
Record Date
          §2010-SepA
Sector
          §Technology
Industry
          §Healthcare Information Services
Exchange
          §BB
Data Provided Without Warranty